Workflow
限制性股票与股票期权激励计划
icon
Search documents
捷邦科技(301326.SZ):预计2025年亏损4000万元至5500万元
Sou Hu Cai Jing· 2026-01-26 12:18
Core Viewpoint - The company, Jiebang Technology (301326.SZ), expects a loss of 40 million to 55 million yuan in 2025, with a non-recurring loss projected between 45 million to 60 million yuan, primarily due to increased competition in the consumer electronics industry and rising costs associated with new business expansions [1]. Group 1: Financial Performance - The company's net profit attributable to shareholders is expected to decline year-on-year due to intensified competition and pricing pressures in the consumer electronics sector, leading to a decrease in sales gross margin for certain precision components and structural parts [1]. - The company anticipates an increase in costs and expenses related to strengthening its industrial layout and expanding into new businesses and products during the reporting period [1]. Group 2: Cost and Impairment - In the first half of 2025, the company plans to grant part of the restricted stock and stock option incentive plan for 2024, resulting in an estimated cost of approximately 20.39 million yuan, which is an increase of about 13.2 million yuan compared to the same period last year [1]. - The company is conducting impairment tests on assets showing signs of impairment for 2025, with the final impairment provision amount to be determined after audit by a qualified securities and futures auditing firm [1].
捷邦科技:预计2025年度净利润亏损4000万元~5500万元
Sou Hu Cai Jing· 2026-01-26 11:06
Group 1 - The company expects a net loss attributable to shareholders of 40 million to 55 million yuan for 2025, compared to a net loss of 19.35 million yuan in the same period last year [1] - The primary reason for the performance change is intensified competition in the consumer electronics industry and pricing pressure from clients, leading to a decrease in the selling price of certain precision components and structural parts [1] - The company has increased costs due to strengthening its industrial layout and expanding into new businesses and products, with related cost expenses rising [1] Group 2 - The company will recognize approximately 20.39 million yuan in costs related to the restricted stock and stock option incentive plan for 2025, an increase of about 13.2 million yuan compared to the same period last year [1]
爱旭股份:关于2025年限制性股票与股票期权激励计划预留授予限制性股票登记完成的公告
Core Viewpoint - Aishuo Co., Ltd. has completed the registration of restricted stock grants as part of its 2025 incentive plan, with a total of 3.9345 million shares reserved for granting [1] Group 1 - The announcement was made on the evening of November 18, detailing the completion of the registration work for the restricted stock grants [1] - The registration date for the reserved restricted stock grants is November 17, 2025 [1] - The total number of restricted stock grants registered is 3.9345 million shares [1]
上海海利生物技术股份有限公司 2025年第三季度报告
Zheng Quan Ri Bao· 2025-10-29 23:24
Core Viewpoint - The company has announced significant changes regarding its stock incentive plan, including the repurchase and cancellation of certain restricted stocks and stock options due to unmet performance conditions and employee departures [52][64][66]. Financial Data - The company reported a cash dividend of 0.0784 yuan per share, totaling approximately 51.4 million yuan distributed to shareholders [5]. - The total number of shares will decrease from 655,662,200 to 651,904,700 after the repurchase of 3,757,500 restricted stocks [50][66]. Board Meeting and Resolutions - The fifth board meeting was held on October 28, 2025, where several key resolutions were passed, including the approval of the third-quarter report and the adjustment of the stock incentive plan [10][12][58]. - The board approved the appointment of Sigma Accounting Firm for the 2025 financial audit [12]. Stock Incentive Plan Adjustments - The company will repurchase 243,750 restricted stocks due to unmet conditions for the second release period of the stock incentive plan [64][66]. - The repurchase price for restricted stocks has been adjusted to 4.6729 yuan per share, and the exercise price for stock options has been adjusted to 9.4429 yuan per option [61][63]. Upcoming Events - The company will hold a second extraordinary general meeting on November 14, 2025, to discuss the resolutions passed by the board [20][32]. - An investor performance briefing is scheduled for November 21, 2025, to discuss the third-quarter results and address investor inquiries [24][25].
深圳市索菱实业股份有限公司2025年第三季度报告
Core Viewpoint - The company has disclosed its third-quarter financial report, ensuring the accuracy and completeness of the information provided, and has made several strategic decisions regarding investments and financing [1][2][3]. Financial Data - The third-quarter financial report has not been audited [3]. - The company does not require retrospective adjustments or restatements of previous accounting data [3]. - There are no non-recurring profit and loss items applicable for this quarter [3]. Shareholder Information - The company has received warning letters from the China Securities Regulatory Commission regarding compliance issues [5]. - The company has established a wholly-owned subsidiary in Chengdu with a registered capital of 20 million RMB to support business expansion [6]. Financing Activities - The company plans to apply for a total credit limit of up to 500 million RMB from financial institutions for the year 2025 [7]. - The company has signed financing contracts with various banks, including a 50 million RMB financing agreement with Huaxia Bank and a 120 million RMB agreement with Industrial and Commercial Bank of China [9][10]. Performance Commitments - The company has received a performance compensation payment of 318.54 million RMB from its major shareholder, Tanghe Holdings, due to unmet profit commitments for the years 2022-2024 [10]. Legal Matters - The company has resolved previous legal issues, resulting in the lifting of freezes on its subsidiary's equity and the release of property from mortgage [11]. - Ongoing litigation related to securities false statements is being monitored [12]. Stock Incentive Plans - The company has approved the release of restrictions on stock options and restricted shares for various incentive plans, with specific numbers of shares and options being made available for trading [15][16][17][18][19][20][21][22].
*ST双成:9月19日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-09-19 11:26
Group 1 - The core point of the article is that *ST Shuangcheng (SZ 002693) announced the convening of its 22nd meeting of the fifth board of directors on September 19, 2025, to discuss the granting of restricted stocks and stock options under the 2025 incentive plan [1] - For the first half of 2025, *ST Shuangcheng's revenue composition was 89.3% from industrial operations and 10.7% from services [1] - As of the time of reporting, *ST Shuangcheng had a market capitalization of 3.1 billion yuan [1]
开立医疗: 第四届董事会第十次会议决议公告
Zheng Quan Zhi Xing· 2025-09-05 12:20
Group 1 - The company held its 10th meeting of the 4th Board of Directors on August 29, 2025, with all 7 directors present, meeting the legal requirements [1][2] - The Board approved the draft of the 2025 Employee Stock Ownership Plan (ESOP) to enhance talent retention and align employee interests with shareholder value [2][3] - The voting result for the ESOP was unanimous, with 6 votes in favor and no opposition, representing 100% of the votes cast [3][4] Group 2 - The company plans to implement a 2025 Restricted Stock and Stock Option Incentive Plan to attract and retain talent while ensuring alignment of interests among shareholders, the company, and employees [5][6] - The voting result for the incentive plan was also unanimous, with 6 votes in favor and no opposition, representing 100% of the votes cast [6][7] - The Board proposed to authorize the shareholders' meeting to grant the Board the authority to manage the implementation of the incentive plan, including adjustments based on policy changes [7][8] Group 3 - The company will submit the ESOP and the incentive plan for approval at the upcoming shareholders' meeting [3][4] - The Board will also seek authorization to handle necessary administrative tasks related to the incentive plan, including approvals and registrations with relevant authorities [8][9] - The company aims to ensure the effective implementation of both plans to support its long-term development strategy [5][6]
开立医疗: 关于召开2025年第一次临时股东大会的通知
Zheng Quan Zhi Xing· 2025-09-05 12:20
Meeting Information - The company will hold its first extraordinary general meeting of shareholders for 2025 on September 23, 2025, at 14:30 [1] - Voting will be conducted both on-site and through an online voting system provided by the Shenzhen Stock Exchange [2] Voting Procedures - Shareholders can choose either on-site voting or online voting, but not both. Duplicate votes will be counted based on the first submission [2][6] - The registration deadline for shareholders is September 17, 2025, at the close of trading [2] Agenda Items - The meeting will discuss several proposals, including the authorization of the board to handle matters related to the 2025 employee stock ownership plan and the 2025 restricted stock and stock option incentive plan [3][4] - Proposals requiring special resolutions need to be approved by more than two-thirds of the voting rights held by attending shareholders [3] Registration and Attendance - Legal representatives of corporate shareholders must present specific documentation to register for the meeting [4][5] - Individual shareholders must also provide identification and shareholder account information for registration [5] Online Voting Process - Detailed procedures for participating in online voting are provided, including the need for identity verification through the Shenzhen Stock Exchange's systems [6]
*ST双成: 海南双成药业股份有限公司第五届董事会第二十一次会议决议公告
Zheng Quan Zhi Xing· 2025-09-01 13:09
Core Viewpoint - The company has approved a series of resolutions regarding the 2025 Restricted Stock and Stock Option Incentive Plan, aimed at enhancing corporate governance and motivating key employees for sustainable development [1][2][3]. Group 1: Board Meeting Details - The fifth session of the board's 21st meeting was held on August 30, 2025, with six directors participating and the meeting chaired by Chairman Wang Chengdong [1]. - The meeting complied with relevant laws, regulations, and the company's articles of association [1]. Group 2: Incentive Plan Resolutions - The board approved the draft of the 2025 Restricted Stock and Stock Option Incentive Plan to improve governance and establish a robust incentive mechanism [1][2]. - The plan aims to enhance the sense of responsibility and mission among the management team and core employees for the company's sustainable development [1]. Group 3: Voting Results - The voting results for the incentive plan draft showed 5 votes in favor, 1 abstention, and no opposition [2][5]. - Li Jianming, an associated director, abstained from voting on the proposal [2][5]. Group 4: Authorization for Implementation - The board proposed to authorize itself to handle matters related to the 2025 incentive plan, including determining grant dates and adjusting stock options in case of capital changes [3][4]. - The authorization includes managing the qualifications of participants and handling necessary documentation for granting stock options [4][5]. Group 5: Upcoming Shareholder Meeting - The board has proposed to convene the second extraordinary general meeting of shareholders in 2025 to discuss the incentive plan [5].
深圳市索菱实业股份有限公司关于回购注销2023年限制性股票与股票期权激励计划部分限制性股票暨通知债权人的公告
Core Viewpoint - Shenzhen Sogou Industrial Co., Ltd. announced the repurchase and cancellation of 400,000 restricted stocks due to one incentive object no longer qualifying for the incentive plan [1][2]. Group 1: Stock Repurchase and Cancellation - The company will repurchase and cancel 400,000 restricted stocks held by one incentive object who has left the company, resulting in a reduction of the total share capital by the same amount [2]. - The repurchase and cancellation procedures will be completed in accordance with relevant laws and regulations, and the company will disclose the completion announcement in a timely manner [2]. Group 2: Notification to Creditors - The company has notified creditors that they have 45 days from the announcement date to request debt repayment or provide corresponding guarantees [2]. - If creditors do not exercise their rights within the specified period, the company will proceed with the repurchase and cancellation according to legal procedures [2]. Group 3: Shareholder Meeting - The first temporary shareholder meeting of 2025 was held on August 12, 2025, with a total of 404 shareholders present, representing 324,525,483 shares, which is 37.6233% of the total voting shares [8]. - The meeting adopted resolutions including the use of idle funds for entrusted financial management and the repurchase and cancellation of restricted stocks [11][12]. Group 4: Voting Results - The resolution for the repurchase and cancellation of restricted stocks received 324,097,383 votes in favor, accounting for 99.8681% of the valid votes cast [13]. - Among minority shareholders, 98.8035% voted in favor of the resolution, indicating strong support for the company's actions [13].